Position in LLY
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$9,766,959
+$2,277,272 QoQ
Shares Held
8,143
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#1,272
of 4,605 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cohen Capital Management, Inc. holds $39,718,306 across 10 Drug Manufacturers - General names. LLY ranks #3 (24.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
74,849 | $11,730,335 | |
| 2 | JNJ |
Johnson & Johnson
|
42,818 | $10,874,487 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
8,143 | $9,766,959 | |
| 4 | ABBV |
AbbVie Inc.
|
10,042 | $2,526,968 | |
| 5 | PFE |
Pfizer Inc
|
67,037 | $1,614,250 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
14,350 | $826,847 | |
| 7 | AMGN |
Amgen Inc
|
2,224 | $805,354 | |
| 8 | MRK |
Merck & Co., Inc.
|
5,967 | $766,759 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,766,959 | 8,143 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $7,489,687 | 8,143 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $8,653,324 | 8,052 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $6,372,576 | 8,352 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $363,260 | 466 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $384,874 | 466 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $260,936 | 338 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $275,527 | 311 | Shares | Sole | 2024-10-30 | |
| No filing history on record for this holder in this stock. | ||||||